Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Infection and Chemotherapy is Scopus-indexed (Q2, CiteScore 5.1), WoS ESCI, DOAJ. Published by Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, Korean Society for AIDS, Korean Society of Pediatric Infectious Diseases.
Checked against the index lists dated .
ISSN 2092-6448Verify ISSN ↗2093-2340Verify ISSN ↗
Publisher: Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, Korean Society for AIDS, Korean Society of Pediatric Infectious Diseases
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 120 / 361 | 66th | Q2 |
| Pharmacology (medical) | 98 / 278 | 64th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q2, CiteScore 5.1.
Infection and Chemotherapy is Q2 in Infectious Diseases (rank 120 of 361) and Q2 in Pharmacology (medical) (rank 98 of 278), by CiteScore 2025.
Infection and Chemotherapy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.1, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.719, quartile Q2, with an H-index of 44.
The publisher lists an article processing charge of about US$200 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Infection and Chemotherapy is published by Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, Korean Society for AIDS, Korean Society of Pediatric Infectious Diseases. Its print ISSN is 2092-6448 and its online ISSN is 2093-2340.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Infection and Chemotherapy has an h-index of 51 and a 2-year mean of 2.56 citations per paper (OpenAlex). Its Scopus CiteScore is 5.1, quartile Q2. On 2-year citations it ranks #123 of 354 Scopus journals in Infectious Diseases.
Infection and Chemotherapy published 86 papers in 2025; its busiest recent year was 2022 with 101. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from South Korea (59.7%), Indonesia (8.1%) and India (7.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.